IGSF9 and cancer: Previous studies reported that IGSF9 was aberrantly expressed in different cancer types, such as down-regulation in melanoma, colorectal familial adenomatous polyposis [19, 20], and upregulation in gallbladder cancer, ovarian cancer, and endometrial cancer [21–23].